Prediction resource could make CRISPR-Cas9 editing more reliable
The largest study of CRISPR action to date has developed a method to predict the exact mutations CRISPR-Cas9 gene editing can introduce to a cell. Researchers at the Wellcome Sanger Institute edited 40,000 different pieces of DNA and analysed a thousand million resulting DNA sequences to reveal the effects of the gene editing and develop a machine learning predictive tool of the outcomes. This will assist researchers who are using CRISPR-Cas9 to research disease mechanisms and drug targets.
Reported today in Nature Biotechnology (27th November), the new resource will enable scientists to predict the best sequences to target to make CRISPR-Cas9 gene editing more reliable, and therefore cheaper and more efficient.
CRISPR-Cas9* is a gene editing technology that enables researchers to cut DNA at any position in the genome, to create mutations and switch off specific genes. This vital technology is used by scientists worldwide to study which genes are important for various conditions, from cancer to rare diseases. It is also now being trialled therapeutically to correct harmful mutations in people’s genes.
A specific guide RNA binds to an exact sequence of target DNA, guiding the Cas9 ‘scissors’ to cut the DNA at the right place. However, it is difficult to predict exactly what the final mutations will be, as further changes often take place when the cell repairs the break, rejoining the two cut ends of the DNA.
To study this, the researchers created over 40,000 pairs of different target DNA and guide RNA, and carried out CRISPR-Cas9 gene editing. By deep sequencing of each pair in different cells, they were able to analyse in detail how the DNA was cut and rejoined. They found that the repair depended on the exact sequence of DNA and guide and discovered that it was reproducible within the same sequence.
The researchers then used the huge quantity of sequence data to create a machine learning computational tool, which created general rules to determine the outcome of the repair. This programme – called FORECasT – enabled them to predict the repaired sequence, using the targeted DNA sequence alone.
“We have carried out the largest, most comprehensive study on CRISPR-Cas9 action to date, and analysed more than a thousand million DNA sequences to allow us to study the process. We demonstrated that specific target sequences were repaired by the cell in the same way, proving that the action of the cell mechanisms is reproducible.”
Dr Luca Crepaldi, joint first author on the study from the Wellcome Sanger Institute
“The discovery of reproducible DNA repair after CRISPR-Cas9 editing, combined with the vast amount of sequence data we generated, meant that we could create a predictive tool using machine learning methods. Our resource can predict the exact mutations resulting from CRISPR-Cas9 gene editing, just from the sequence of the target DNA. It will save time and resources for future CRISPR-Cas9 applications, and is openly available for use by all researchers using gene editing to study health and disease.”
Dr Felicity Allen, joint first author from the Wellcome Sanger Institute
“CRISPR-Cas9 is an extremely important system for introducing mutations into DNA for research, and prospective therapeutic purposes. Our research allows scientists to understand its workings much better, and our transformational method enables people to predict the effects of each CRISPR-Cas9 edit in a cell. This allows better design of editing experiments, and may lead to future therapeutic applications.”
Dr Leopold Parts, senior author on the paper from the Wellcome Sanger Institute
The Latest on: Gene editing
via Google News
The Latest on: Gene editing
- After a year, we still know nothing about China’s gene-edited babieson November 30, 2019 at 6:48 am
“Nothing has changed,” said Dr. Kiran Musunuru, a University of Pennsylvania geneticist who just published a book about gene editing and the CRISPR babies case. “I think we’re farther from governing ...
- Mark Buchanan: Gene editing might alter our DNA. It might destroy our humanity tooon November 30, 2019 at 1:00 am
Biologists recently revealed a new form of the gene-editing tool known as CRISPR that allows researchers to make precise changes to almost any element of DNA, permanently altering cellular ...
- 1 year later, mystery surrounds China’s gene-edited babieson November 29, 2019 at 5:23 pm
FILE - In this Nov. 28, 2018, file photo, He Jiankui, a Chinese researcher, speaks during the Human Genome Editing Conference in Hong Kong. Chinese scientist He Jiankui shocked the world by claiming ...
- CRISPR-Switch regulates sgRNA activity by Cre recombination for sequential editing of two locion November 29, 2019 at 2:21 am
Furthermore, we design sequential CRISPR-Switch-based editing of two loci in a strictly programmable manner and determined the order of mutagenic events that leads to development of glioblastoma in ...
- Gene editing kills malaria carrying mosquitoeson November 28, 2019 at 2:45 am
Researchers in England wipe out a population of malaria carrying mosquitoes in a laboratory using gene editing, raising renewed hopes of eradicating the disease in the wild. Stuart McDill reports.
- High efficacy full allelic CRISPR/Cas9 gene editing in tetraploid potatoon November 27, 2019 at 3:26 am
Highly increased editing efficiencies in the Granular Bound Starch Synthase gene at the protoplast level were obtained by replacement of the Arabidopsis U6 promotor, driving expression of the CRISPR ...
- Is CRISPR Therapeutics the Best Gene-Editing Stock Right Now?on November 26, 2019 at 12:35 pm
CRISPR Therapeutics (NASDAQ:CRSP) made news recently after unveiling some impressive results for its signature gene-editing drug, CTX001. Coupled with an earlier analyst upgrade from Oppenheimer, the ...
- Genomics ETFs Surge on CRISPR's Gene Editing Progresson November 26, 2019 at 7:51 am
Notably, the studies were evaluating the CRISPR/Cas9 gene-editing therapy CTX001 for two severe blood disorders — sickle cell disease (SCD) and adult transfusion-dependent b-thalassemia (TDT). CRISPR ...
- CRISPR gene-editing treatment shows success in first human patientson November 20, 2019 at 8:23 am
In sickle cell disease, red blood cells take on a sickle shape, which can cause clotting and pain. An investigational therapy using the revolutionary gene-editing technology CRISPR has shown promising ...
via Bing News